XML 19 R7.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive (Loss) Income
Treasury Stock
Non- controlling Interests
Beginning balances at Dec. 31, 2021 $ 728,941   $ 1,470 $ 312,538 $ 475,262   $ (55,950) $ (5,791) $ 1,412
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares issued for employee stock ownership plan 2,951   4 2,947          
Ending balances at Mar. 31, 2022 657,492   1,460 305,880 490,200   (135,849) (5,642) 1,443
Beginning balances at Dec. 31, 2021 728,941   1,470 312,538 475,262   (55,950) (5,791) 1,412
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income attributable to noncontrolling interests and Tompkins Financial Corporation 44,205       44,142       63
Other comprehensive loss (122,919)           (122,919)    
Subtotal comprehensive income (loss) attributable to noncontrolling interests and Tompkins Financial Corporation (78,714)                
Cash dividends (16,634)       (16,634)        
Net exercise of stock options (42)     (42)          
Common stock repurchased and returned to unissued status (14,128)   (18) (14,110)          
Stock-based compensation expense 1,973     1,973          
Directors deferred compensation plan 0     56       (56)  
Restricted stock activity (29)   (2) (27)          
Ending balances at Jun. 30, 2022 624,318   1,454 303,335 502,770   (178,869) (5,847) 1,475
Beginning balances at Mar. 31, 2022 657,492   1,460 305,880 490,200   (135,849) (5,642) 1,443
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income attributable to noncontrolling interests and Tompkins Financial Corporation 20,901       20,869       32
Other comprehensive loss (43,020)           (43,020)    
Subtotal comprehensive income (loss) attributable to noncontrolling interests and Tompkins Financial Corporation (22,119)                
Cash dividends (8,299)       (8,299)        
Common stock repurchased and returned to unissued status (3,758)   (5) (3,753)          
Stock-based compensation expense 1,028     1,028          
Directors deferred compensation plan 0     205       (205)  
Restricted stock activity (26)   (1) (25)          
Ending balances at Jun. 30, 2022 624,318   1,454 303,335 502,770   (178,869) (5,847) 1,475
Beginning balances at Dec. 31, 2022 617,390 $ (65) 1,456 302,763 526,727 $ (65) (208,689) (6,279) 1,412
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income attributable to noncontrolling interests and Tompkins Financial Corporation 27,918       27,856       62
Other comprehensive loss 13,169           13,169    
Subtotal comprehensive income (loss) attributable to noncontrolling interests and Tompkins Financial Corporation 41,087                
Cash dividends (17,423)       (17,423)        
Net exercise of stock options (118)   (118)          
Common stock repurchased and returned to unissued status (6,378)   (11) (6,367)          
Stock-based compensation expense 2,155     2,155          
Directors deferred compensation plan 0     (94)       94  
Restricted stock activity (207)   (1) (206)          
Ending balances at Jun. 30, 2023 636,441   1,444 298,133 537,095   (195,520) (6,185) 1,474
Beginning balances at Mar. 31, 2023 649,765   1,456 303,357 537,331   (187,846) (5,976) 1,443
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income attributable to noncontrolling interests and Tompkins Financial Corporation 8,506       8,475       31
Other comprehensive loss (7,674)           (7,674)    
Subtotal comprehensive income (loss) attributable to noncontrolling interests and Tompkins Financial Corporation 832                
Cash dividends (8,711)       (8,711)        
Net exercise of stock options (10)     (10)          
Common stock repurchased and returned to unissued status (6,378)   (11) (6,367)          
Stock-based compensation expense 1,110     1,110          
Directors deferred compensation plan 0     209       (209)  
Restricted stock activity (167)   (1) (166)          
Ending balances at Jun. 30, 2023 $ 636,441   $ 1,444 $ 298,133 $ 537,095   $ (195,520) $ (6,185) $ 1,474